Safety & Efficacy Study of EGF Cancer Vaccine to Treat Stage IV Biomarker Positive, Wild Type EGF-R NSCLC Patients

PHASE3TerminatedINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

May 1, 2019

Study Completion Date

September 6, 2019

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
BIOLOGICAL

EGF Vaccine

1.2mL of conjugate-adjuvant mix injection at four sites during the Post First-Line Chemotherapy. Reduced dose of injection at two sites during the Pre-Progression Phase.

Trial Locations (51)

Unknown

"Multiprofile Hospital for Active Treatment (MHAT)-Dobrich AD", Dobrich

"MHAT for Women's Health-NadezhdaOOD", Sofia

Nemocnice Na Pleši s.r.o. Oddelení klinické onkologie a radioterapie, Nová Ves pod Pleší

Pardubická krajská nemocnice, a.s.c, Pardubice

Thomayerova nemocnice, Prague

Cancer Center of Adjara, Batumi

Clinic Health House, Tbilisi

Institute of Clinical Oncology, Tbilisi

JSC, Maritime Hospital, Tbilisi

JSC, Neo Medi, Tbilisi

LTD, High Technology Medical Centre, University Clinic, Tbilisi

LTD, Medulla - Chemotherapy and Immunotherapy Clinic, Tbilisi

Research Institute Of Clinical Medicine, Tbilisi

Universitätsklinikum Halle (Saale) Klinik und Poliklinik fuer Innere Medizin, Halle

Augusta-Kranken-Anstalt Bochum, Bochum

Kliniken der Stadt Köln GmbH, Cologne

KRH Klinikum Siloah Hannover - Oststadt, Hanover

Thoraxklinik Heidelberg gGmbH, Heidelberg

Universitätsklinikum Schleswig-Holstein (UKSH), Kiel

Universitätsklinikum Leipzig - AöR, Leipzig

LMU-München, München

Mühlen-Apotheke, Oststeinbek

Hospital Sultanah Bahiyah, Alor Star

Sarawak General Hospital, Kuching

Mahkota Medical Center, Malacca

Hospital Pulau Pinang, Pulau Pinang

Perpetual Succour Hospital, Lahug

Makati Medical Center, Makati

The Medical City, Pasig

Lung Center of the Philippines, Quezon City

Davao Doctors hospital, Davao City

Cancer Research Center, Manila

Philippine General Hospital, Manila

Samodzielny Publiczny Zespol Gruzlicy i Chorob Pluc, Olsztyn

Szpital Specjalistyczny w Prabutach, Prabuty

"Centrul de Oncologie Sf. Nectarie", Craiova

S.C. R.T.C. Radiology Therapeutic Center S.R.L., Otopeni

SC Oncomed SRL, Târgu Mureş

Hospital Universitario Quiron Dexeus, Barcelona

Hospital General Universitario Gregorio Marañón, Madrid

Hospital Universitario Fundación Jimenez Díaz, Madrid

Hospital Universitario Puerta de Hierro, Madrid

Hospital Regional Universitario de Málaga, Málaga

Lopburi Cancer Hospital, Mueang

Songklanagarind Hospital, Hat Yai

Bangkok Hospital Chiang Mai, Bangkok

Lampang Cancer Hospital, Lampang

Buddhachinaraj Hospital, Phitsanulok

Aberdeen Royal Infirmary, Aberdeen

Nottingham University Hospitals, Nottingham

University Hospital Southampton NHS Trust, Southampton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bioven Europe

INDUSTRY